Institute of Bioorganic Chemistry

http://iboch.bas-net.by/  

Synthesis Technology of Artificial Genes

COUNTRY OF ORIGIN

IDENTIFIER

TO6561

PUBLISHED

2023-03-24

LAST UPDATE

2023-03-24

DEADLINE

Linked profile in other language
Responsible
Aleksej Yantsevich
+375 17 357 8761
info@iboch.by
Summary
The Institute of Bioorganic Chemistry offers consumers a technology for the synthesis of artificial genes under a commercial agreement with technical assistance and is looking for partners to conclude a recearch cooperation agreement.
Description
The technology makes it possible to obtain synthetic genes (double-stranded DNA of a given sequence), including those built into plasmid vectors. To illustrate the capabilities of the technology, a demo layout has been developed.

Applications: biotechnology, biopharmaceutics, scientific research.

Included in the Catalog of exhibits (TOP DEVELOPMENTS by exposition clusters) of the exhibition of scientific and technological achievements "Intellectual Belarus 2023".
Advantages and Innovations
Innovative technology for obtaining synthetic genes.
Stage of development
Available for demonstration (TRL5,6)
Funding source
State budged
Internal
IPR status
Exclusive rights
Patents granted
Secret know-how
Comments regarding IPS status
Protected by a patent of the Republic of Belarus.
Sector group
BioChemTech
Healthcare

Organization information

Type
R&D institution
Year established
1974
NACE keywords
C.21.20 - Manufacture of pharmaceutical preparations
C.21.10 - Manufacture of basic pharmaceutical products
C.20.59 - Manufacture of other chemical products n.e.c.
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Already engaged in transnational cooperation
Yes
Additional comments
Main activities:
- fundamental and applied research in the field of chemistry, structure and function of biopolymers and low molecular weight bioregulators, including proteins, nucleic acids and their components, phospholipids, steroids, prostaglandins, brassinosteroids, ecdysteroids;
- development and pilot production of immunochemical and molecular biological reagent kits for medical and veterinary diagnostics;
- development and production of pharmaceutical substances, hormonal preparations and biospecific hemosorbents;
- development of technologies for the production and use of growth stimulants and plant protection products;
- experimental and clinical pharmacology, pharmacy and drug technology, toxicology, human and animal biochemistry, biomedical and pharmaceutical chemistry;
- preclinical, bioequivalent and pharmaceutical trials.

The Institute of Bioorganic Chemistry successfully develops international relations in the main areas of its research. Currently, the Institute conducts joint research with scientific institutes of the CIS countries, Germany, USA, Canada, Sweden, Finland, Denmark, Holland, Vietnam and other countries.
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Commercial agreement with technical assistance
Research cooperation agreement
Type and role of partner sought
Consumers interested in purchasing artificial gene synthesis technology under a commercial agreement with technical assistance.

Partners interested in improving of technology for the synthesis of artificial genes under a research cooperation agreement.
Type and size of partner sought
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University

Attachments

Views: 880
Statistics since 24.03.2023 14:44:48